Treatment with the drug clodronate does not improve overall survival for men with localized prostate cancer or delay the disease?s progression to metastatic cancer, according to the results of a randomized clinical trial.
Medical research scientists in public health and other areas routinely make ethical value judgments, even if they’re not aware of it, according to a new Weill Cornell Medical College research study. And not only do these judgments not lead to bias necessarily, but they can make for better research.
A report released by the Australian Institute of Health and Welfare suggests that some asthma medications are not being used in the optimal way by most people.
Women should not drink alcohol while pregnant or planning to become pregnant, the Royal Australasian College of Physicians was told in Melbourne.
Scientists from the Center for Applied Medical Research (CIMA) from the University of Navarra investigate whether cardiotrophin 1, a molecule that can be measured in blood, can be used as a diagnostic marker for hypertensive cardiopathy.
For the first time, a group based cognitive behavioural therapy (CBT) intervention has been demonstrated to markedly increase acceptance and adherence to CPAP treatment for sufferers of obstructive sleep apnea (OSA).
Maintaining high standards of safety in every aspect of health and medical services is critical to Australia?s health system.
The Department of Biotechnology, Ministry of Science & Technology, Government of India and the International AIDS Vaccine Initiative signed an agreement today to address a major obstacle in AIDS vaccine development: the design of candidate vaccines to elicit neutralizing antibodies against HIV.
A U.S. Supreme Court decision in favor of KSR International Corp. on Monday strengthens challenges against overreaching human embryonic stem cell patents held by an affiliate of the University of Wisconsin, the Foundation for Taxpayer and Consumer Rights (FTCR) and the Public Patent Foundation (PUBPAT) said today.
Scientists from the Center for Applied Medical Research from the University of Navarra investigate whether cardiotrophin 1, a molecule that can be measured in blood, can be used as a diagnostic marker for hypertensive cardiopathy.